Skip to main content

Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome

Abstract

Chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS) is one of the four category prostatitis, and the prevalence is over 90–95% in prostatitis. Because of its pain and obstructive voiding difficulties, it severely affects the quality of life of the patient. However, the standard treatment is still unclear. Given the lack of proven efficacy of conventional therapies (such as antibiotics, anti-inflammatory medications, and alpha-blockers), many patients have turned to phytotherapy and other alternative treatments. In recent years, phytotherapy and physical therapy have advanced a lot because of the safety, efficacy and high compliance. This review covers phytotherapy (quercetin, bee pollen, pumpkin seed oil, eviprostat, terpene mixture) and physical therapy (acupuncture, shock wave, thermobalancing, transurethral needle ablation, transcutaneous electrical nerve stimulation sono-electro-magnetic therapy) commonly used in chronic prostatitis to help the clinician and researchers.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, Waqar M, Zhou X (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064–1076

    Article  Google Scholar 

  2. 2.

    Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V, Vietto V (2018) Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. BJU Int. https://doi.org/10.1111/bju.14492

    Article  PubMed  Google Scholar 

  3. 3.

    Mo MQ, Long LL, Xie WL, Chen S, Zhang WH, Luo CQ, Deng LW (2014) Sexual dysfunctions and psychological disorders associated with type IIIa chronic prostatitis: a clinical survey in China. Int Urol Nephrol 46(12):2255–2261. https://doi.org/10.1007/s11255-014-0810-2

    Article  PubMed  Google Scholar 

  4. 4.

    Pontari MA (2007) Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 8(4):307–312

    Article  Google Scholar 

  5. 5.

    Westesson KE, Shoskes DA (2010) Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat? Curr Urol Rep 11(4):261–264. https://doi.org/10.1007/s11934-010-0111-y

    Article  PubMed  Google Scholar 

  6. 6.

    Herati AS, Moldwin RM (2013) Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome. World J Urol 31(4):761–766. https://doi.org/10.1007/s00345-013-1097-0

    Article  PubMed  Google Scholar 

  7. 7.

    Kurita M, Yamaguchi H, Okamoto K, Kotera T, Oka M (2018) Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain. Prostate 78(15):1157–1165. https://doi.org/10.1002/pros.23690

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Polackwich A, Shoskes D (2016) Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis 19(2):132

    CAS  Article  Google Scholar 

  9. 9.

    Gul O, Eroglu M, Ozok U (2001) Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 32(3):433–436

    CAS  Article  Google Scholar 

  10. 10.

    Cai T, Verze P, La Rocca R, Palmieri A, Tiscione D, Luciani LG, Mazzoli S, Mirone V, Malossini G (2017) The clinical efficacy of pollen extract and vitamins on chronic prostatitis/chronic pelvic pain syndrome is linked to a decrease in the pro-inflammatory cytokine interleukin-8. World J Mens Health 35(2):120–128

    Article  Google Scholar 

  11. 11.

    Tuğcu V, Taşçı Aİ, Fazlıoğlu A, Gürbüz G, Özbek E, Şahin S, Kurtuluş F, Çek M (2007) A placebo-controlled comparison of the efficiency of triple-and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51(4):1113–1118

    Article  Google Scholar 

  12. 12.

    Shoskes DA, Manickam K (2003) Herbal and complementary medicine in chronic prostatitis. World J Urol 21(2):109–113

    Article  Google Scholar 

  13. 13.

    Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brähler E, Weidner W (2009) A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis–chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56(3):544–551

    Article  Google Scholar 

  14. 14.

    Habib F, Ross M, Buck A, Ebeling L, Lewenstein A (1990) In vitro evaluation of the pollen extract cernitin T-60, in the regulation of prostate cell growth. Br J Urol 66(4):393–397

    CAS  Article  Google Scholar 

  15. 15.

    Morais M, Moreira L, Feás X, Estevinho LM (2011) Honeybee-collected pollen from five Portuguese Natural Parks: palynological origin, phenolic content, antioxidant properties and antimicrobial activity. Food Chem Toxicol 49(5):1096–1101

    CAS  Article  Google Scholar 

  16. 16.

    Maruyama H, Sakamoto T, Araki Y, Hara H (2010) Anti-inflammatory effect of bee pollen ethanol extract from Cistus sp. of Spanish on carrageenan-induced rat hind paw edema. BMC Complement Altern Med 10:30. https://doi.org/10.1186/1472-6882-10-30

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Kamijo T, Sato S, Kitamura T (2001) Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats. Prostate 49(2):122–131

    CAS  Article  Google Scholar 

  18. 18.

    Lesjak M, Beara I, Simin N, Pintać D, Majkić T, Bekvalac K, Orčić D, Mimica-Dukić N (2018) Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J Funct Foods 40:68–75

    CAS  Article  Google Scholar 

  19. 19.

    Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G et al (2017) Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep 38:819–828

    CAS  Article  Google Scholar 

  20. 20.

    Gardi C, Bauerova K, Stringa B, Kuncirova V, Slovak L, Ponist S, Drafi F, Bezakova L, Tedesco I, Acquaviva A (2015) Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Arch Biochem Biophys 583:150–157

    CAS  Article  Google Scholar 

  21. 21.

    Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54(6):960–963

    CAS  Article  Google Scholar 

  22. 22.

    Meng LQ, Yang FY, Wang MS, Shi BK, Chen DX, Chen D, Zhou Q, He QB, Ma LX, Cheng WL (2018) Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways. Prostate 78(11):790–800

    CAS  Article  Google Scholar 

  23. 23.

    Procida G, Stancher B, Cateni F, Zacchigna M (2013) Chemical composition and functional characterisation of commercial pumpkin seed oil. J Sci Food Agric 93(5):1035–1041

    CAS  Article  Google Scholar 

  24. 24.

    Stevenson DG, Eller FJ, Wang L, Jane J-L, Wang T, Inglett GE (2007) Oil and tocopherol content and composition of pumpkin seed oil in 12 cultivars. J Agric Food Chem 55(10):4005–4013

    CAS  Article  Google Scholar 

  25. 25.

    Tsai Y-S, Tong Y-C, Cheng J-T, Lee C-H, Yang F-S, Lee H-Y (2006) Pumpkin seed oil and phytosterol-F can block testosterone/prazosin-induced prostate growth in rats. Urol Int 77(3):269–274

    CAS  Article  Google Scholar 

  26. 26.

    Ejike CE, Ezeanyika LU (2011) Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. Urol Int 87(2):218–224

    Article  Google Scholar 

  27. 27.

    Tantawy SA, Elgohary HM, Kamel DM (2018) Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol 10:95

    CAS  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Tagaya M, Oka M, Ueda M, Takagaki K, Tanaka M, Ohgi T, Yano J (2009) Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis. Cytokine 47(3):185–193

    CAS  Article  Google Scholar 

  29. 29.

    Oka M, Ueda M, Oyama T, Kyotani J, Tanaka M (2009) Effect of the phytotherapeutic agent Eviprostat® on 17β-estradiol-induced nonbacterial inflammation in the rat prostate. Prostate 69(13):1404–1410

    CAS  Article  Google Scholar 

  30. 30.

    Kawai Y, Oka M, Kyotani J, Oyama T, Matsumoto S, Kakizaki H (2013) Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying. Neurourol Urodyn 32(7):1031–1037

    CAS  Article  Google Scholar 

  31. 31.

    Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C (2015) Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study. BMC Urol 15(1):120

    Article  Google Scholar 

  32. 32.

    Tsunemori H, Sugimoto M, Xia Z, Taoka R, Oka M, Kakehi Y (2011) Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis. Urology 77(6):1507.e1515–1507.e1520

    Article  Google Scholar 

  33. 33.

    Shibuya S, Xia Z, Sugimoto M, Ueda N, Haba R, Kakehi Y (2014) The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate. Urology 83(3):528–534

    Article  Google Scholar 

  34. 34.

    Chua ME, Park JH, Castillo JC, Morales ML Jr (2013) Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. Urolithiasis 41(2):143–151. https://doi.org/10.1007/s00240-012-0538-3

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Lee CB, Ha US, Lee SJ, Kim SW, Cho YH (2006) Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol 24(1):55–60. https://doi.org/10.1007/s00345-005-0039-x

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Wang S, Zhang D, Hu J, Jia Q, Xu W, Su D, Song H, Xu Z, Cui J, Zhou M, Yang J, Xiao J (2017) A clinical and mechanistic study of topical borneol-induced analgesia. EMBO Mol Med 9(6):802–815. https://doi.org/10.15252/emmm.201607300

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Zhou JY, Tang FD, Mao GG, Bian RL (2004) Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacol Sin 25(4):480–484

    CAS  PubMed  Google Scholar 

  38. 38.

    Liu BP, Wang YT, Chen SD (2016) Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Int Urol Nephrol 48(12):1977–1991. https://doi.org/10.1007/s11255-016-1403-z

    Article  PubMed  Google Scholar 

  39. 39.

    Qin Z, Zang Z, Zhou K, Wu J, Zhou J, Kwong JSW, Liu Z (2018) Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham acupuncture controlled trial. J Urol 200(4):815–822. https://doi.org/10.1016/j.juro.2018.05.001

    Article  PubMed  Google Scholar 

  40. 40.

    Sahin S, Bicer M, Eren GA, Tas S, Tugcu V, Tasci AI, Cek M (2015) Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham-controlled trial. Prostate Cancer Prostatic Dis 18(3):249–254. https://doi.org/10.1038/pcan.2015.13

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Ohlsen BA (2013) Acupuncture and traditional chinese medicine for the management of a 35-year-old man with chronic prostatitis with chronic pelvic pain syndrome. J Chiropr Med 12(3):182–190. https://doi.org/10.1016/j.jcm.2013.10.004

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Zhou M, Yang M, Chen L, Yu C, Zhang W, Ji J, Chen C, Shen X, Ying J (2017) The effectiveness of long-needle acupuncture at acupoints BL30 and BL35 for CP/CPPS: a randomized controlled pilot study. BMC Complement Altern Med 17(1):263. https://doi.org/10.1186/s12906-017-1768-2

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Lee SW, Liong ML, Yuen KH, Krieger JN (2014) Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complement Ther Med 22(6):965–969. https://doi.org/10.1016/j.ctim.2014.10.010

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Schmitz C, Csaszar NB, Rompe JD, Chaves H, Furia JP (2013) Treatment of chronic plantar fasciopathy with extracorporeal shock waves (review). J Orthop Surg Res 8:31. https://doi.org/10.1186/1749-799X-8-31

    Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, Patella V (2009) The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord 10:54. https://doi.org/10.1186/1471-2474-10-54

    Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Vulpiani MC, Trischitta D, Trovato P, Vetrano M, Ferretti A (2009) Extracorporeal shockwave therapy (ESWT) in Achilles tendinopathy. A long-term follow-up observational study. J Sports Med Phys Fitness 49(2):171–176

    CAS  PubMed  Google Scholar 

  47. 47.

    Salama AB, Abouelnaga WA (2018) Effect of radial shock wave on chronic pelvic pain syndrome/chronic prostatitis. J Phys Ther Sci 30(9):1145–1149. https://doi.org/10.1589/jpts.30.1145

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Zimmermann R, Cumpanas A, Miclea F, Janetschek G (2009) Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol 56(3):418–424. https://doi.org/10.1016/j.eururo.2009.03.043

    Article  PubMed  Google Scholar 

  49. 49.

    Al Edwan GM, Muheilan MM, Atta ON (2017) Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis. Ann Med Surg (Lond) 14:12–17. https://doi.org/10.1016/j.amsu.2016.12.051

    Article  Google Scholar 

  50. 50.

    Guu SJ, Geng JH, Chao IT, Lin HT, Lee YC, Juan YS, Liu CC, Wang CJ, Tsai CC (2018) Efficacy of low-intensity extracorporeal shock wave therapy on men with chronic pelvic pain syndrome refractory to 3-as therapy. Am J Mens Health 12(2):441–452. https://doi.org/10.1177/1557988317736585

    Article  PubMed  Google Scholar 

  51. 51.

    Vahdatpour B, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S (2013) Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urol 2013:972601. https://doi.org/10.1155/2013/972601

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, Russo S, Suzuki H (2005) Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 12(2):89–96. https://doi.org/10.1016/j.niox.2004.12.005

    CAS  Article  PubMed  Google Scholar 

  53. 53.

    Aghajanyan IG, Allen S (2016) Positive response to thermobalancing therapy enabled by therapeutic device in men with non-malignant prostate diseases: BPH and chronic prostatitis. Diseases. https://doi.org/10.3390/diseases4020018

    Article  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Allen S (2017) The vascular factor plays the main role in the cause of pain in men with chronic prostatitis and chronic pelvic pain syndrome: the results of clinical trial on thermobalancing therapy. Diseases. https://doi.org/10.3390/diseases5040025

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Jin JX, Wang HZ, Zhai ZX, Ma BL, Li QF, Xiao N, Wang ZP, Rodriguez R (2017) Transrectal microwave thermotherapy causing a short-time influence on sperm quality in Chinese chronic nonbacterial prostatitis patients. Asian J Androl 19(5):548–553. https://doi.org/10.4103/1008-682X.185852

    CAS  Article  PubMed  Google Scholar 

  56. 56.

    Gao M, Ding H, Zhong G, Lu J, Wang H, Li Q, Wang Z (2012) The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology 79(2):391–396. https://doi.org/10.1016/j.urology.2011.08.046

    Article  PubMed  Google Scholar 

  57. 57.

    Allen S, Aghajanyan IG (2017) Efficacy of thermobalancing therapy for chronic prostatitis/chronic pelvic pain syndrome, confirmed by clinical study, may suggest etiology and pathophysiology of this disease. Can Urol Assoc J. https://doi.org/10.5489/cuaj.4473

    Article  PubMed  PubMed Central  Google Scholar 

  58. 58.

    Chiang PH, Chiang CP (2004) Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa. Int J Urol 11(2):97–102

    Article  Google Scholar 

  59. 59.

    Lee KC, Jung PB, Park HS, Whang JH, Lee JG (2002) Transurethral needle ablation for chronic nonbacterial prostatitis. BJU Int 89(3):226–229

    CAS  Article  Google Scholar 

  60. 60.

    Catley MJ, Gibson W, Wand BM, Meads C, O'Connell NE (2015) Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain ‐ an overview of Cochrane reviews. Cochrane Database Syst Rev 2:CD011890. https://doi.org/10.1002/14651858.CD011890

    Article  Google Scholar 

  61. 61.

    Bennett MI, Johnson MI, Brown SR, Radford H, Brown JM, Searle RD (2010) Feasibility study of transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. J Pain 11(4):351–359. https://doi.org/10.1016/j.jpain.2009.08.002

    Article  PubMed  Google Scholar 

  62. 62.

    Sikiru L, Shmaila H, Muhammed SA (2008) Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial. Int Braz J Urol 34(6):708–713 (discussion 714)

    Article  Google Scholar 

  63. 63.

    Schneider MP, Tellenbach M, Mordasini L, Thalmann GN, Kessler TM (2013) Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int 112(2):E159–E163. https://doi.org/10.1111/bju.12005

    Article  PubMed  Google Scholar 

  64. 64.

    Kessler TM, Mordasini L, Weisstanner C, Juni P, da Costa BR, Wiest R, Thalmann GN (2014) Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial. PLoS One 9(12):e113368. https://doi.org/10.1371/journal.pone.0113368

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant numbers 30973003; 30901993), and the Administration of TCM of Jiangsu Province (Grant number LZ 11093).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Xiaohui Zhou.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hu, M., Wazir, J., Ullah, R. et al. Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome. Int Urol Nephrol 51, 1081–1088 (2019). https://doi.org/10.1007/s11255-019-02161-x

Download citation

Keywords

  • Chronic prostatitis
  • Alternative therapies
  • Phytotherapy
  • Physical therapy
  • Quality of life